biOasis Technologies Ord Shs V.BTI

Primary Symbol: V.BTI.H Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by jdstoxon Feb 09, 2018 10:23am

178 Views

Post# 27532988

RE:amazes me how

Oh yeah, jekyl, things is awful.

End of the world.

No hope.

None of the monkeys will sign the waiver.

Total rebellion.

We don't need Near Human Primates.

We need Barely Human Primates.

Volunteers?

Jekyl?

No waiver needed, buddy.

We're going to auction off the opportunity to give you the dose.

We expect to avoid a financing with the money we raise with that one.

Jekyl, you long ago passed from the conscious consideration of investors. But that doesn't mean we wouldn't treat you the same as any other ape in our world.

jdstox

Bullboard Posts

Geologica Resource: Polymetallic upside at a depressed price